PK
SLXN

Pflug Koory’s Silexion Therapeutics SLXN Stock Holding History

Pflug Koory’s Portfolio SLXN Stock Details SLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$84 Hold
33
– – ﹤0.01% 425
2026
Q1 		$426 Hold
33
– – ﹤0.01% 415
2025
Q4 		$639 Hold
33
– – ﹤0.01% 408
2025
Q3 		$1.13K Buy
+33
New +$2.74K ﹤0.01% 396

Other funds holding SLXN

MA
Montag & Associates Atlanta, Georgia $2.37B AUM 28.86% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Pflug Koory's SLXN Position: Q2 2026 in Review

Pflug Koory held its Silexion Therapeutics (SLXN) position steady in Q2 2026 at 33 shares worth $84. The position accounts for ﹤0.01% of the portfolio, ranked #425.

Pflug Koory first reported a position in SLXN in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.13K in Q3 2025. 3 funds tracked by Wall St. Rank hold SLXN as of Q2 2026.

  • Pflug Koory held 33 shares of Silexion Therapeutics worth $84 as of Q2 2026.
  • Pflug Koory left its Silexion Therapeutics share count unchanged in Q2 2026.
  • Silexion Therapeutics made up ﹤0.01% of Pflug Koory's portfolio in Q2 2026, its #425 holding.
  • Pflug Koory first reported a position in Silexion Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Pflug Koory's Silexion Therapeutics position peaked at $1.13K in Q3 2025.
  • 3 funds tracked by Wall St. Rank held Silexion Therapeutics as of Q2 2026.

Based on Pflug Koory's 13F filing for Q2 2026, filed 21 Jul 2026.